TruNativ bags $30M Series B from OrbiMed to scale clean-label nutrition across channels
Mumbai-based TruNativ, founded 2019, closed a $30 million Series B led by OrbiMed. Capital will fund expansion across D2C, quick commerce, modern trade and pharmacy, while scaling its B2B2C ingredient arm supplying Indian consumer brands.
What happened
TruNativ, a Mumbai-based clean-label nutrition D2C startup, raised $30 million Series B led by OrbiMed. Funds will expand distribution across D2C, quick
Key facts
- $30 million
- Series B
- founded 2019
Why this matters
TruNativ's B2B2C ingredient arm supplying Indian consumer brands makes it a strategically interesting partner or tuck-in target for FMCG majors looking to onboard clean-label formulation capability quickly.